4.8 Article

Three-Dimensional Hierarchical Plasmonic Nano-Architecture Enhanced Surface-Enhanced Raman Scattering Immunosensor for Cancer Biomarker Detection in Blood Plasma

期刊

ACS NANO
卷 7, 期 6, 页码 4967-4976

出版社

AMER CHEMICAL SOC
DOI: 10.1021/nn4018284

关键词

biosensor; biomarker; surface-enhanced Raman scattering; cancer; surface plasmon; blood plasma

资金

  1. NSF [EPS 1003907]
  2. NASA-WV Space Grant Consortium
  3. West Virginia University Research Corporation
  4. West Virginia EPSCoR Office
  5. NIH [P30 GM103488, P30 RR 032138, R01 HL056888, RO1 CA134573]
  6. National Science Foundation [1102689]
  7. Natural Sciences and Engineering Research Council of Canada
  8. Fonds de la recherche sur la nature et les technologies
  9. Mylan Chair of Pharmacology at the WVU Health Sciences Center
  10. Alexander B. Osborn Hematopoietic Malignancy and Transplantation Program
  11. WV Research Trust Fund
  12. Division Of Graduate Education
  13. Direct For Education and Human Resources [1102689] Funding Source: National Science Foundation
  14. Office Of The Director
  15. Office of Integrative Activities [1003907] Funding Source: National Science Foundation

向作者/读者索取更多资源

A three-dimensional (3D) hierarchical plasmonic nano-architecture has been designed for a sensitive surface-enhanced Raman scattering (SERS) immunosensor for protein biomarker detection. The capture antibody molecules are immobilized on a plasmonic gold triangle nanoarray pattern. On the other hand, the detection antibody molecules are linked to the gold nanostar@Raman reporter@silica sandwich nanoparticles. When protein biomarkers are present, the sandwich nanoparticles are captured over the gold triangle nanoarray, forming a confined 3D plasmonic field, leading to the enhanced electromagnetic field in intensity and in 3D space. As a result, the Raman reporter molecules are exposed to a high density of hot spots, which amplifies the Raman signal remarkably, improving the sensitivity of the SERS immunosensor. This SERS immunosensor exhibits a wide linear range (0.1 pg/mL to 10 ng/mL) and a low limit of detection (7 fg/mL) toward human immunoglobulin G protein In the buffer solution. This biosensor has been successfully used for detection of the vascular endothelial growth factor In the human blood plasma from clinical breast cancer patient samples.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据